Bio Techne Corp Stock Investor Sentiment

TECH Stock  USD 58.47  3.16  5.71%   
Under 63% of all Bio Techne's traders are looking to take a long position. The analysis of overall sentiment of trading Bio Techne Corp stock suggests that some investors are interested at this time. Bio Techne's investing sentiment shows overall attitude of investors towards Bio Techne Corp.

Comfort Level 63

 Interested

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Bio Techne's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Bio Techne Corp.

Bio Historical Sentiment

Although Bio Techne's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Bio, such as negative comments on social media and news outlets, may cause fear in the market and push Bio Techne's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Bio.

Bio Techne Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Bio Techne can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Bio Techne Corp Historical Investor Sentiment

Investor biases related to Bio Techne's public news can be used to forecast risks associated with an investment in Bio. The trend in average sentiment can be used to explain how an investor holding Bio can time the market purely based on public headlines and social activities around Bio Techne Corp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Bio Techne's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Bio Techne and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Bio Techne news discussions. The higher the estimate score, the more favorable the investor's outlook on Bio Techne.

Bio Techne Maximum Pain Price Across October 17th 2025 Option Contracts

Bio Techne's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Bio Techne close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Bio Techne's options.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of Bio Techne's Stock prices. Below is the latest headlines and news related to Bio Techne Corp Stock. Current markets are strongly bullish. About 75% of major world exchanges and indexes are currently up. See today's market update for more information.
There is far too much social signal, news, headlines, and media speculation about Bio Techne that are available to investors today. This information is accessible both publicly - through Bio Techne's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Bio-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Bio Techne news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Bio Techne relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Bio Techne's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Bio Techne alpha.

Bio Largest EPS Surprises

Earnings surprises can significantly impact Bio Techne's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2006-01-31
2005-12-310.10.110.0110 
2005-10-27
2005-09-300.10.110.0110 
2004-08-10
2004-06-300.090.08-0.0111 
2004-04-27
2004-03-310.080.090.0112 
2004-01-27
2003-12-310.070.080.0114 
2003-10-23
2003-09-300.070.080.0114 
View All Earnings Estimates
a minute ago at finance.yahoo.com         
BIO-TECHNE SURPASSES 10,000 PEER-REVIEWED PUBLICATIONS CITING RNAscope TECHNOLOGY
Yahoo News
a day ago at thelincolnianonline.com         
Bio-Techne versus Neurogene Financial Survey
news
2 days ago at thelincolnianonline.com         
Q2 EPS Estimates for Bio-Techne Increased by Leerink Partnrs
news
3 days ago at finance.yahoo.com         
Bio-Techne Stock Is Up, What You Need To Know
Yahoo News
3 days ago at stockstory.org         
Disposition of 48176 shares by Kim Kelderman of Bio Techne at 44.33 subject to Rule 16b-3
news
few days ago at thelincolnianonline.com         
Formidable Asset Management LLC Sells 740 Shares of Bio-Techne Corp
news
over a week ago at finance.yahoo.com         
Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Fin...
Yahoo News
over a week ago at thelincolnianonline.com         
Segall Bryant Hamill LLC Lowers Position in Bio-Techne Corp
news
over a week ago at finance.yahoo.com         
INCY or TECH Which Is the Better Value Stock Right Now?
Yahoo News
over a week ago at finance.yahoo.com         
Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultr...
Yahoo News
over a week ago at finance.yahoo.com         
Spear Bio Announces Strategic Partnership with Bio-Techne to Accelerate the Deployment of Its Next-G...
Yahoo News
over a week ago at finance.yahoo.com         
Heres Headwaters Capital Managements Investment Thesis for Bio-Techne
Yahoo News
over a week ago at finance.yahoo.com         
Disposition of 32933 shares by Kim Kelderman of Bio Techne at 51.42 subject to Rule 16b-3
Yahoo News
over a week ago at express.co.uk         
Key Reform UK moves that prove Nigel Farage is set on smashing uniparty system
news
over a week ago at finance.yahoo.com         
Bio-Technes Simple Western Technology Utilized in Recent FDA Approval of ZEVASKYN Cell-Based Gene Th...
Yahoo News
There is far too much social signal, news, headlines, and media speculation about Bio Techne that are available to investors today. This information is accessible both publicly - through Bio Techne's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Bio-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Bio Techne news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Bio Techne relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Bio Techne's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Bio Techne alpha.

Bio Techne Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Techne Reports Q3 Earnings What Key Metrics Have to Say
05/07/2025
2
Nigel Farage gets another huge boost for Reform UK in humiliation for Tories
05/21/2025
 
Bio Techne dividend paid on 30th of May 2025
05/30/2025
3
Spotting Winners Bio-Techne And Research Tools Consumables Stocks In Q1
06/03/2025
4
Disposition of 1280 shares by Herr Amy E. of Bio Techne at 44.33 subject to Rule 16b-3
06/09/2025
5
Bio-Techne Corp Shares Acquired by Legacy Advisors LLC
06/25/2025
6
Bio-Technes New USP Deal on mAb and Gene Therapy May Boost Its Stock - Zacks Investment Research
06/30/2025
7
Assessing Bio-Techne Insights From 7 Financial Analysts
07/09/2025
8
Disposition of 32933 shares by Kim Kelderman of Bio Techne at 51.42 subject to Rule 16b-3
07/15/2025
9
Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results
07/17/2025
10
Disposition of 48176 shares by Kim Kelderman of Bio Techne at 44.33 subject to Rule 16b-3
07/22/2025

Complementary Tools for Bio Stock analysis

When running Bio Techne's price analysis, check to measure Bio Techne's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Techne is operating at the current time. Most of Bio Techne's value examination focuses on studying past and present price action to predict the probability of Bio Techne's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Techne's price. Additionally, you may evaluate how the addition of Bio Techne to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments